Ryann Sohaney1,2, Huiying Yin1,3, Vahakn Shahinian1,3, Rajiv Saran1,3,4, Nilka Ríos Burrows5, Meda E Pavkov5, Tanushree Banerjee6, Chi-Yuan Hsu7, Neil Powe6, Diane Steffick1,3, Kara Zivin8,9, Michael Heung. 1. Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. 2. Division of Nephrology, Department of Internal Medicine, Henry Ford Health System, Detroit, Michigan. 3. Kidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, Michigan. 4. Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan. 5. Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia. 6. Department of Medicine, University of California San Francisco, San Francisco, California. 7. Division of Nephrology, School of Medicine, University of California, San Francisco, California. 8. Department of Psychiatry, University of Michigan, Ann Arbor, Michigan. 9. Center for Clinical Management Research, Veterans Affairs Ann Arbor Health Care System, Ann Arbor, Michigan.
Abstract
BACKGROUND AND OBJECTIVES: AKI, a frequent complication among hospitalized patients, confers excess short- and long-term mortality. We sought to determine trends in in-hospital and 1-year mortality associated with AKI as defined by Kidney Disease Improving Global Outcomes consensus criteria. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective cohort study used data from the national Veterans Health Administration on all patients hospitalized from October 1, 2008 to September 31, 2017. AKI was defined by Kidney Disease Improving Global Outcomes serum creatinine criteria. In-hospital and 1-year mortality trends were analyzed in patients with and without AKI using Cox regression with year as a continuous variable. RESULTS: We identified 1,688,457 patients and 2,689,093 hospitalizations across the study period. Among patients with AKI, 6% died in hospital, and 28% died within 1 year. In contrast, in-hospital and 1-year mortality rates were 0.8% and 14%, respectively, among non-AKI hospitalizations. During the study period, there was a slight decline in crude in-hospital AKI-associated mortality (hazard ratio, 0.98 per year; 95% confidence interval, 0.98 to 0.99) that was attenuated after accounting for patient demographics, comorbid conditions, and acute hospitalization characteristics (adjusted hazard ratio, 0.99 per year; 95% confidence interval, 0.99 to 1.00). This stable temporal trend in mortality persisted at 1 year (adjusted hazard ratio, 1.00 per year; 95% confidence interval, 0.99 to 1.00). CONCLUSIONS: AKI associated mortality remains high, as greater than one in four patients with AKI died within 1 year of hospitalization. Over the past decade, there seems to have been no significant progress toward improving in-hospital or long-term AKI survivorship.
BACKGROUND AND OBJECTIVES: AKI, a frequent complication among hospitalized patients, confers excess short- and long-term mortality. We sought to determine trends in in-hospital and 1-year mortality associated with AKI as defined by Kidney Disease Improving Global Outcomes consensus criteria. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective cohort study used data from the national Veterans Health Administration on all patients hospitalized from October 1, 2008 to September 31, 2017. AKI was defined by Kidney Disease Improving Global Outcomes serum creatinine criteria. In-hospital and 1-year mortality trends were analyzed in patients with and without AKI using Cox regression with year as a continuous variable. RESULTS: We identified 1,688,457 patients and 2,689,093 hospitalizations across the study period. Among patients with AKI, 6% died in hospital, and 28% died within 1 year. In contrast, in-hospital and 1-year mortality rates were 0.8% and 14%, respectively, among non-AKI hospitalizations. During the study period, there was a slight decline in crude in-hospital AKI-associated mortality (hazard ratio, 0.98 per year; 95% confidence interval, 0.98 to 0.99) that was attenuated after accounting for patient demographics, comorbid conditions, and acute hospitalization characteristics (adjusted hazard ratio, 0.99 per year; 95% confidence interval, 0.99 to 1.00). This stable temporal trend in mortality persisted at 1 year (adjusted hazard ratio, 1.00 per year; 95% confidence interval, 0.99 to 1.00). CONCLUSIONS: AKI associated mortality remains high, as greater than one in four patients with AKI died within 1 year of hospitalization. Over the past decade, there seems to have been no significant progress toward improving in-hospital or long-term AKI survivorship.
Authors: Edward D Siew; Josh F Peterson; Svetlana K Eden; Adriana M Hung; Theodore Speroff; T Alp Ikizler; Michael E Matheny Journal: J Am Soc Nephrol Date: 2011-12-08 Impact factor: 10.121
Authors: Jeremiah R Brown; Michael E Rezaee; William M Hisey; Kevin C Cox; Michael E Matheny; Mark J Sarnak Journal: Am J Nephrol Date: 2016-04-29 Impact factor: 3.754
Authors: Morgan E Grams; Sushrut S Waikar; Blaithin MacMahon; Seamus Whelton; Shoshana H Ballew; Josef Coresh Journal: Clin J Am Soc Nephrol Date: 2014-01-23 Impact factor: 8.237
Authors: Tal Mandelbaum; Daniel J Scott; Joon Lee; Roger G Mark; Atul Malhotra; Sushrut S Waikar; Michael D Howell; Daniel Talmor Journal: Crit Care Med Date: 2011-12 Impact factor: 7.598
Authors: Emily J See; Kushani Jayasinghe; Neil Glassford; Michael Bailey; David W Johnson; Kevan R Polkinghorne; Nigel D Toussaint; Rinaldo Bellomo Journal: Kidney Int Date: 2018-11-23 Impact factor: 10.612
Authors: Raymond K Hsu; Charles E McCulloch; R Adams Dudley; Lowell J Lo; Chi-yuan Hsu Journal: J Am Soc Nephrol Date: 2012-12-06 Impact factor: 10.121
Authors: Jay L Xue; Frank Daniels; Robert A Star; Paul L Kimmel; Paul W Eggers; Bruce A Molitoris; Jonathan Himmelfarb; Allan J Collins Journal: J Am Soc Nephrol Date: 2006-02-22 Impact factor: 10.121